Literature DB >> 2088479

Differential effects of c-myb and c-fes antisense oligodeoxynucleotides on granulocytic differentiation of human myeloid leukemia HL60 cells.

S Ferrari1, A Donelli, R Manfredini, M Sarti, R Roncaglia, E Tagliafico, E Rossi, G Torelli, U Torelli.   

Abstract

To gain some insight into the role of c-myb and c-fes in myeloid differentiation, the authors have analyzed the ability of HL60 cells to differentiate in response to several different inducers after inhibition of c-myb and c-fes function. This function has been inhibited almost completely by using deoxynucleotides complementary to two 18-nucleotide sequences of c-myb and c-fes encoding mRNA. After 5 days in culture, in several separate experiments with different oligomer preparations, more than 90% growth inhibition was observed in c-myb antisense-treated HL60 cells. At this time, independent of the differentiation inducer used, c-myb antisense-treated HL60 cells differentiate only along the monocytic pathway, whereas in sense oligomer-treated cultures, retinoic acid and dimethyl sulfoxide induced granulocytic differentiation. No perturbation of the HL60 cell growth was observed after 5 days of treatment with antisense c-fes oligomer. However, induction to granulocytic differentiation by retinoic acid and dimethyl sulfoxide resulted in progressive cell death, whereas monocytic differentiation by other differentiation inducers was only marginally affected. These results suggest that granulocytic, unlike monocytic, differentiation requires c-myb-conditioned proliferation and the activity of the protein encoded by c-fes.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2088479

Source DB:  PubMed          Journal:  Cell Growth Differ        ISSN: 1044-9523


  8 in total

1.  Biochemical correction of X-CGD by a novel chimeric promoter regulating high levels of transgene expression in myeloid cells.

Authors:  Giorgia Santilli; Elena Almarza; Christian Brendel; Uimook Choi; Chiara Beilin; Michael P Blundell; Sneha Haria; Kathryn L Parsley; Christine Kinnon; Harry L Malech; Juan A Bueren; Manuel Grez; Adrian J Thrasher
Journal:  Mol Ther       Date:  2010-10-26       Impact factor: 11.454

2.  The myeloid-cell-specific c-fes promoter is regulated by Sp1, PU.1, and a novel transcription factor.

Authors:  A Heydemann; G Juang; K Hennessy; M S Parmacek; M C Simon
Journal:  Mol Cell Biol       Date:  1996-04       Impact factor: 4.272

3.  Enhanced endotoxin sensitivity in fps/fes-null mice with minimal defects in hematopoietic homeostasis.

Authors:  Ralph A Zirngibl; Yotis Senis; Peter A Greer
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

4.  Impaired adult myeloid progenitor CMP and GMP cell function in conditional c-myb-knockout mice.

Authors:  Yen K Lieu; E Premkumar Reddy
Journal:  Cell Cycle       Date:  2012-08-23       Impact factor: 4.534

5.  MYB induces the expression of the oncogenic corepressor SKI in acute myeloid leukemia.

Authors:  Miriam Frech; Sabine Teichler; Christine Feld; Caroline Bouchard; Hannah Berberich; Katharina Sorg; Marco Mernberger; Lars Bullinger; Uta-Maria Bauer; Andreas Neubauer
Journal:  Oncotarget       Date:  2018-04-27

6.  Inhibition of leukaemia cell proliferation by folic acid-polylysine-mediated introduction of c-myb antisense oligodeoxynucleotides into HL-60 cells.

Authors:  G Citro; C Szczylik; P Ginobbi; G Zupi; B Calabretta
Journal:  Br J Cancer       Date:  1994-03       Impact factor: 7.640

7.  Inhibition of c-fes expression by an antisense oligomer causes apoptosis of HL60 cells induced to granulocytic differentiation.

Authors:  R Manfredini; A Grande; E Tagliafico; D Barbieri; P Zucchini; G Citro; G Zupi; C Franceschi; U Torelli; S Ferrari
Journal:  J Exp Med       Date:  1993-08-01       Impact factor: 14.307

8.  MicroRNA-150 expression induces myeloid differentiation of human acute leukemia cells and normal hematopoietic progenitors.

Authors:  Valerie A Morris; Ailin Zhang; Taimei Yang; Derek L Stirewalt; Ranjani Ramamurthy; Soheil Meshinchi; Vivian G Oehler
Journal:  PLoS One       Date:  2013-09-24       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.